J&J's William Weldon: Leadership in a Decentralized Company
Episode Description
Consumers tend to associate Johnson & Johnson with Band-Aids and baby shampoo, but those well-known products are only part of a much larger picture, according to William Weldon, chairman and CEO of the New Brunswick, N.J.-based firm. In fact, Weldon has the mind-boggling task of overseeing more than 200 operating companies across three sectors, including consumer products, pharmaceuticals and medical devices. On June 18, Weldon spoke at the 2008 Wharton Leadership Conference about the challenges of running the Johnson & Johnson family of companies. In an interview with Knowledge@Wharton, he elaborated on how J&J's decentralized structure informs his leadership style and what he sees as key issues for the health care industry in the coming decade, among other topics.
Brief Summary
William Weldon discusses Johnson & Johnson's decentralized structure, leadership challenges, and innovation strategies in healthcare.
Key points
- Decentralization at J&J. Weldon explains how J&J's decentralized structure fosters leadership and innovation.
- Challenges in Healthcare. Weldon outlines the major challenges facing the healthcare industry today.
- Risks in Pharmaceuticals. Weldon discusses the inherent risks associated with drugs and healthcare.
Ask about Knowledge at Wharton
Episode highlights
- Decentralization at J&JWeldon explains how J&J's decentralized structure fosters leadership and innovation.“Decentralization gives you a tremendous opportunity to develop people.”3:46Jun 25, 2008
- Challenges in HealthcareWeldon outlines the major challenges facing the healthcare industry today.“The cost of healthcare is a big challenge.”12:30Jun 25, 2008
- Risks in PharmaceuticalsWeldon discusses the inherent risks associated with drugs and healthcare.“Drugs by definition have good effects and side effects.”12:49Jun 25, 2008





